Bogle Investment Management’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-118,773
Closed -$2.98M 435
2016
Q4
$2.98M Sell
118,773
-52,834
-31% -$1.25M 0.21% 146
2016
Q3
$4.01M Buy
+171,607
New +$4.03M 0.29% 113
2016
Q2
Sell
-205,158
Closed -$3.48M 534
2016
Q1
$3.48M Sell
205,158
-97,500
-32% -$2M 0.23% 130
2015
Q4
$6.72M Buy
+302,658
New +$6.3M 0.48% 80
2014
Q4
Sell
-138,574
Closed -$1.73M 451
2014
Q3
$1.73M Buy
138,574
+109,604
+378% +$1.53M 0.11% 198
2014
Q2
$396K Sell
28,970
-15,647
-35% -$205K 0.03% 287
2014
Q1
$538K Sell
44,617
-138,578
-76% -$1.59M 0.04% 304
2013
Q4
$2.25M Buy
+183,195
New +$2.15M 0.19% 154
2013
Q3
Sell
-195,148
Closed -$1.75M 384
2013
Q2
$1.75M Buy
+195,148
New +$1.97M 0.21% 149

Other funds holding OME

Bogle Investment Management's OME Position: Q1 2017 in Review

Bogle Investment Management sold out of Omega Protein (OME) in Q1 2017, closing a stake of 118,773 shares — an estimated $2.98M sold.

Bogle Investment Management first reported a position in OME in Q2 2013 and held it in 9 quarters. The position peaked at $6.72M in Q4 2015. 144 funds tracked by Wall St. Rank hold OME as of Q1 2017.

  • Bogle Investment Management reported no remaining Omega Protein position as of Q1 2017 after selling out during the quarter.
  • Bogle Investment Management sold 118,773 Omega Protein shares in Q1 2017, an estimated $2.98M.
  • Bogle Investment Management first reported a position in Omega Protein in Q2 2013 and held it in 9 quarters.
  • Bogle Investment Management's Omega Protein position peaked at $6.72M in Q4 2015.
  • 144 funds tracked by Wall St. Rank held Omega Protein as of Q1 2017.

Based on Bogle Investment Management's 13F filing for Q1 2017, filed 12 May 2017.